Belite Bio Inc ADR (BLTE) — Cash Flow Reinvestment Rate
Latest as of September 2022:
0.00x
Belite Bio Inc ADR (BLTE) has a Cash Flow Reinvestment Rate of 0.00x as of September 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $741.50. Explore BLTE operating cash flow to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$741.50
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Belite Bio Inc ADR (None–None)
Year-by-year capital reinvestment analysis for Belite Bio Inc ADR. For live market cap and broader valuation context, see BLTE stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow